InterCure Ltd. (TLV:INCR)

Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
497.70
-0.30 (-0.06%)
Oct 26, 2025, 10:06 AM IDT
-0.06%
Market Cap267.44M
Revenue (ttm)243.12M
Net Income (ttm)-70.93M
Shares Out54.51M
EPS (ttm)-1.41
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,221
Average Volume73,565
Open498.00
Previous Close498.00
Day's Range496.20 - 498.00
52-Week Range454.10 - 686.60
Beta0.65
RSI36.91
Earnings DateDec 1, 2025

About InterCure

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel. [Read more]

Sector Healthcare
Founded 1994
Employees 320
Stock Exchange Tel Aviv Stock Exchange
Ticker Symbol INCR
Full Company Profile

Financial Performance

In 2024, InterCure's revenue was 238.85 million, a decrease of -32.82% compared to the previous year's 355.55 million. Losses were -67.80 million, 9.42% more than in 2023.

Financial Statements

News

There is no news available yet.